Results 11 to 20 of about 11,061 (219)
Linfoma no Hodgkin primario de vagina [PDF]
Revista chilena de obstetricia y ginecología, 2013 La afectacion primaria del tracto genital femenino de los linfomas no Hodgkin es poco frecuente (2% de los linfomas primarios extraganglionares). Los organos mas afectados son los ovarios seguidos del cervix, siendo la localizacion endometrial y vaginal extremadamente rara.
Iglesias Rodríguez, María Begoña +5 more
openaire +4 more sources
Miosite do músculo reto medial como forma atípica de apresentação de linfoma tipo MALT: relato de caso [PDF]
, 2014 Here we describe the rare case of a 55-year-old man with medial rectus muscle myositis as an atypical presentation of non-Hodgkin B-cell mucosa-associated lymphoma (MALT).
Dittrich, Mirtha Alicia Ramirez +4 more
core +4 more sources
European Journal of Immunology, Volume 53, Issue 3, March 2023., 2023 Expression of the human fusion oncogene VAV1‐MYO1F in T‐cells in novel transgenic mouse models induces a malignant T lymphoproliferative disease with 100% penetrance in vivo that mimics key aspects of human peripheral T‐cell lymphoma. VAV1‐MYO1F‐expression triggers cell autonomous activation of T‐cell signaling with an activation of the ERK, JNK, and ...
Emma Morrish +5 more
wiley +1 more source
JEADV Clinical Practice, Volume 2, Issue 1, Page 92-100, March 2023., 2023 Abstract Background Anal cancer, although rare, is susceptible to early diagnosis. There is a group of patients who are at high risk for anal cancer, including immunocompromised individuals and particularly people living with human immunodeficiency virus (PLWH).
Rosa A. Feltes Ochoa +5 more
wiley +1 more source
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma
HemaSphere, Volume 7, Issue 2, February 2023., 2023 While most patients with follicular lymphoma (FL) have excellent outcomes with frontline chemoimmunotherapy (CIT), a subset of patients will experience early progression, which is associated with poor subsequent outcomes. Novel biomarkers are needed to identify high‐risk patients earlier.
Reid W. Merryman +27 more
wiley +1 more source
Linfoma folicular duodenal primario: reporte de caso y revisión de la literatura
Revista Colombiana de Gastroenterología, 2021 Los linfomas primarios del tracto gastrointestinal son infrecuentes; sin embargo, son la presentación extranodal más común de los linfomas no Hodgkin. El 30 % de los linfomas no Hodgkin corresponde a linfomas foliculares y, a su vez, cerca del 10 % de ...
Lázaro Antonio Arango Molano +2 more
doaj +1 more source
Jornal de Assistência Farmacêutica e Farmacoeconomia, 2023 Introdução: O tratamento de pacientes com linfoma não-Hodgkin de grandes células B com o medicamento Rituximabe está disponível pelo Sistema Único de Saúde (SUS) desde 2011.
Monica Lopes Sampaio Silva +4 more
doaj +1 more source
Revista Médica Basadrina, 2019 Se ha reportado el caso de una mujer 31 años de edad gestante de 36 ½ semanas a quien se le estableció el diagnóstico de linfoma no Hodgkin de células grandes B difuso primario rectal EC IIE-A. La terapia establecida consistió en cesárea transversa anterior (por ser cesareada anterior) y la terapia oncológica administrada en el Hospital fue Rituximab ...
Ticona Castro, Miguel +2 more
openaire +2 more sources
, 2023 HemaSphere, Volume 7, Issue S3, August 2023.
Maria Stefania Infante +4 more
wiley +1 more source
DOENÇA LINFOPROLIFERATIVA PÓS-TRANSPLANTE TIPO LINFOMA DE HODGKIN – RELATO DE CASO
Hematology, Transfusion and Cell Therapy, 2023 Introdução: A Doença Linfoproliferativa pós-Transplante (PTLD) tipo linfoma de Hodgkin clássico é a forma menos comum de PTLD. Objetivos: Expor a evolução clínica de um paciente transplantado renal com esta rara patologia. Materiais e métodos: Revisão de
NH Dias +4 more
doaj +1 more source